rs9260105

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000396634.5(HLA-A):​c.-281-68G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.044 in 169,394 control chromosomes in the GnomAD database, including 200 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.045 ( 177 hom., cov: 35)
Exomes 𝑓: 0.035 ( 23 hom. )

Consequence

HLA-A
ENST00000396634.5 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.0680

Publications

1 publications found
Variant links:
Genes affected
HLA-A (HGNC:4931): (major histocompatibility complex, class I, A) HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen so that they can be recognized by cytotoxic T cells. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. More than 6000 HLA-A alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0686 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LOC124901298XR_007059541.1 linkn.813+2883C>A intron_variant Intron 1 of 2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HLA-AENST00000396634.5 linkc.-281-68G>T intron_variant Intron 1 of 9 6 ENSP00000379873.1 P04439-1
POLR1HASPENST00000849679.1 linkn.66-13352C>A intron_variant Intron 1 of 5
POLR1HASPENST00000849682.1 linkn.751-13352C>A intron_variant Intron 1 of 3

Frequencies

GnomAD3 genomes
AF:
0.0451
AC:
6854
AN:
152118
Hom.:
176
Cov.:
35
show subpopulations
Gnomad AFR
AF:
0.0707
Gnomad AMI
AF:
0.0647
Gnomad AMR
AF:
0.0325
Gnomad ASJ
AF:
0.0259
Gnomad EAS
AF:
0.00558
Gnomad SAS
AF:
0.0352
Gnomad FIN
AF:
0.0411
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0376
Gnomad OTH
AF:
0.0402
GnomAD4 exome
AF:
0.0346
AC:
594
AN:
17158
Hom.:
23
AF XY:
0.0375
AC XY:
393
AN XY:
10486
show subpopulations
African (AFR)
AF:
0.0685
AC:
20
AN:
292
American (AMR)
AF:
0.0183
AC:
12
AN:
654
Ashkenazi Jewish (ASJ)
AF:
0.0167
AC:
7
AN:
418
East Asian (EAS)
AF:
0.00185
AC:
1
AN:
540
South Asian (SAS)
AF:
0.0346
AC:
178
AN:
5142
European-Finnish (FIN)
AF:
0.0277
AC:
15
AN:
542
Middle Eastern (MID)
AF:
0.0556
AC:
5
AN:
90
European-Non Finnish (NFE)
AF:
0.0388
AC:
331
AN:
8534
Other (OTH)
AF:
0.0264
AC:
25
AN:
946
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
21
42
62
83
104
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0451
AC:
6866
AN:
152236
Hom.:
177
Cov.:
35
AF XY:
0.0452
AC XY:
3361
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.0707
AC:
2937
AN:
41528
American (AMR)
AF:
0.0325
AC:
497
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.0259
AC:
90
AN:
3472
East Asian (EAS)
AF:
0.00559
AC:
29
AN:
5188
South Asian (SAS)
AF:
0.0352
AC:
170
AN:
4830
European-Finnish (FIN)
AF:
0.0411
AC:
435
AN:
10594
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0376
AC:
2556
AN:
68012
Other (OTH)
AF:
0.0402
AC:
85
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
290
580
871
1161
1451
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
82
164
246
328
410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0430
Hom.:
17
Bravo
AF:
0.0464

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
6.2
DANN
Benign
0.74
PhyloP100
-0.068
PromoterAI
0.0079
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs9260105; hg19: chr6-29909675; API